These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 38304432)

  • 1. Diagnostic value of cerebrospinal fluid human epididymis protein 4 for leptomeningeal metastasis in lung adenocarcinoma.
    Li X; Chen K; Li J; Tang X; Ruan H; Guan M
    Front Immunol; 2024; 15():1339914. PubMed ID: 38304432
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CEACAM6 serves as a biomarker for leptomeningeal metastasis in lung adenocarcinoma.
    Wang X; Tang X; Gu J; Sun Z; Yang S; Mu Y; Guan M; Chen K; Liu W; Ruan H; Xu J
    Cancer Med; 2023 Feb; 12(4):4521-4529. PubMed ID: 36082960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gene alternation of cerebrospinal fluid in patients with leptomeningeal metastases of lung adenocarcinoma using next-generation sequencing.
    Yang H; Wen L; Pan Y; Shan C; Hong W; Wang H; Zhou C; Cai L; Zhou C
    BMC Cancer; 2022 May; 22(1):580. PubMed ID: 35614407
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cerebrospinal fluid circulating tumour DNA genotyping and survival analysis in lung adenocarcinoma with leptomeningeal metastases.
    Bai K; Chen X; Qi X; Zhang Y; Zou Y; Li J; Yu L; Li Y; Jiang J; Yang Y; Liu Y; Feng S; Bu H
    J Neurooncol; 2023 Oct; 165(1):149-160. PubMed ID: 37897649
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Auxiliary Diagnostic Value of Tumor Markers in the Cerebrospinal Fluid and Blood for Leptomeningeal Metastasis from Non-small Cell Lung Cancer].
    Lin Y; Li H; Huang M; Yin Z; Wu J
    Zhongguo Fei Ai Za Zhi; 2020 Jun; 23(6):516-525. PubMed ID: 32517459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive RNA analysis of CSF reveals a role for CEACAM6 in lung cancer leptomeningeal metastases.
    Li Y; Polyak D; Lamsam L; Connolly ID; Johnson E; Khoeur LK; Andersen S; Granucci M; Stanley G; Liu B; Nagpal S; Hayden Gephart M
    NPJ Precis Oncol; 2021 Oct; 5(1):90. PubMed ID: 34625644
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Application Value of Serum HE4 in the Diagnosis of Lung Cancer.
    Wang Y; Wang Z; Ding Y; Sun F; Ding X
    Asian Pac J Cancer Prev; 2019 Aug; 20(8):2405-2407. PubMed ID: 31450913
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human epididymal protein 4 and its combined detection show good diagnostic value in lung cancer: A retrospective study.
    Wu L; Chen X; Peng T; Tang E; Bai W; Chen L
    Int J Biol Markers; 2024 Jun; 39(2):141-148. PubMed ID: 38619974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Optimal cut-off values for tumor markers in cerebrospinal fluid with ROC curve analysis.
    Shi Q; Pu CQ; Huang XS; Tian CL; Cao XT
    Front Biosci (Elite Ed); 2011 Jun; 3(4):1259-64. PubMed ID: 21622132
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The joint detection of CEA and ctDNA in cerebrospinal fluid: an auxiliary tool for the diagnosis of leptomeningeal metastases in cancer.
    Wang Y; Luo N; Gao Y; Wu Y; Qin X; Qi Y; Sun T; Tao R; Qi C; Liu B; Yuan S
    J Cancer Res Clin Oncol; 2023 May; 149(5):1679-1690. PubMed ID: 35583828
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum human epididymis protein 4 (HE4) may be a better tumor marker in early lung cancer.
    Zeng Q; Liu M; Zhou N; Liu L; Song X
    Clin Chim Acta; 2016 Apr; 455():102-6. PubMed ID: 26851650
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diagnostic Value of CYFRA 21-1 in the Cerebrospinal Fluid for Leptomeningeal Metastasis.
    Zhang Z; Tian C; Shi Q; Hao J; Zhao N; Liu Z
    Dis Markers; 2017; 2017():2467870. PubMed ID: 28298807
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Significance of Serum HE4, CA125, CA724, and CA19-9 in Patients With Endometrial Cancer.
    Bian J; Sun X; Li B; Ming L
    Technol Cancer Res Treat; 2017 Aug; 16(4):435-439. PubMed ID: 27562869
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New insights into the diagnostic characteristics and clinical application of serum biomarkers for lung cancer, and human epididymis protein 4 as a new biomarker?
    Li M; Zhang Y; Jiang L; Li Y; Li G; Zhou J; Yang C; Li X; Qu W; Chen Y; Chen Q; Wang S; Xing J; Huang H
    Neoplasma; 2022 May; 69(3):729-740. PubMed ID: 35471981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triple test with tumor markers CYFRA 21.1, HE4, and ProGRP might contribute to diagnosis and subtyping of lung cancer.
    Korkmaz ET; Koksal D; Aksu F; Dikmen ZG; Icen D; Maden E; Onder S; Akbiyik F; Emri S
    Clin Biochem; 2018 Aug; 58():15-19. PubMed ID: 29729229
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human Epididymis Protein 4 (HE4) in Patients with Small-Cell Lung Cancer.
    Wojcik E; Tarapacz J; Rychlik U; Stasik Z; Sas-Korczynska B; Skotnicki P; Kulpa JK
    Clin Lab; 2016 Sep; 62(9):1625-1632. PubMed ID: 28164590
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum Human Epididymis Secretory Protein 4 (HE4) is a Potential Prognostic Biomarker in Non-Small Cell Lung Cancer.
    Mo D; He F
    Clin Lab; 2018 Sep; 64(9):1421-1428. PubMed ID: 30274019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of HE4 suppresses tumor growth and invasiveness in lung adenocarcinoma through regulation of EGFR signaling.
    Zhang Y; Yang W; Han X; Qiao Y; Wang H; Chen T; Li T; Ou WB
    Oncol Res; 2024; 32(6):1119-1128. PubMed ID: 38827327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potential for the blood-based biomarkers cytokeratin 19 fragment (CYFRA 21-1) and human epididymal protein 4 (HE4) to detect recurrence during monitoring after surgical resection of adenocarcinoma of the lung.
    Muley T; He Y; Rolny V; Wehnl B; Escherich A; Warth A; Stolp C; Schneider MA; Meister M; Herth FJ; Dayyani F
    Lung Cancer; 2019 Apr; 130():194-200. PubMed ID: 30885344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum CA724 has no diagnostic value for gastrointestinal tumors.
    Cao H; Zhu L; Li L; Wang W; Niu X
    Clin Exp Med; 2023 Oct; 23(6):2433-2442. PubMed ID: 36920593
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.